Table 2

Univariate logistic regression for factors associated with virus-positive exacerbation

Independent variableFrequency (%) in virus-positive exacerbation (n=37)Frequency (%) in virus-negative exacerbation (n=40)OR95% CIp Value
A) Clinical parameters
 Wet cough35 (94.5%)38 (95%)0.90.1 to 6.90.93
 Cough severity score ≥ 236 (97.3%)35 (87.5%)5.10.5 to 46.30.14
 Sputum production16 (43.2%)25 (62.5%)0.40.2 to 1.10.09
Sputum colour≥3 on BronkoTest17 (46%)21 (52.5%)0.80.3 to 1.90.56
 Chest pain5 (13.5%)11 (27.5%)0.40.1 to 1.30.14
 Breathlessness12 (32.4%)12 (30%)1.10.4 to 2.90.81
 Haemoptysis00
 Fever11 (30%)4 (10%)3.81.1 to 13.30.03
 Crackles and/or wheeze23 (62%)13 (32.5%)3.41.3 to 8.70.01
 Hypoxia8 (21.6%)1 (2.5%)10.81.3 to 90.90.03
B) Haematological parameters*
 Raised WCC6 (16.2%)2 (5%)3.70.7 to 19.50.13
 Raised neutrophil %11 (30%)4 (10%)3.81.1 to 13.30.04
 Raised lymphocyte %1 (2.7%)0 (0%)
 Raised monocyte %2 (5.4%)2 (5%)1.10.1 to 8.10.93
 Raised eosinophil %8 (21.6%)8 (20%)1.10.4 to 3.30.86
C) Potential systemic markers
 CRP>3 mg/L26 (70.3%)13 (32.5%)4.91.9 to 12.90.001
 Fibrinogen>4.5 g/L4 (10.8%)3 (7.5%)1.50.3 to 7.20.61
 SAA>5 mg/L16 (43.2%)14 (35%)1.40.6 to 3.50.46
 IL-6>2 ng/L16 (43.2%)10 (25%)2.30.9 to 6.00.09
 PCT>0.09 µg/L5 (13.5%)3 (7.5%)1.90.4 to 8.70.39
D) Lung function
 FEV1<80% predicted12 (54.5%) (n=22)11 (42.3%) (n=26)1.80.6 to 5.60.32
 R5>130% predicted9 (n=26) (34.6%)7 (n=30) (23.3%)5.11.4 to 17.90.35
  • *Cut-offs based on age-dependent criteria.

  • Bold typeface means statistically significant at p<0.2.

  • CRP, C reactive protein; FEV1, forced expiratory volume in first second; IL-6, interleukin 6; PCT, procalcitonin; R5, resistance at 5 Hz; SAA, serum amyloid A; WCC, white cell count.